Search

Rao V Kalla

from Foster City, CA
Age ~58
Get Report
Also known as:
Rao Pushpalatha Kalla, Karla Rao, Kvj Rao
Related to:
Sheshagiri Prahalada Rao, 55Pushpalatha Kalla, 50Gayathri Kalla
Connected to:
Arvind K Kalla, 56Benjamin L Kalla, 36Christine K Kalla, 77Nitin Kalla, 51Vinod Kalla, 51Bashar Kallabat, 54Fadia H Kallabat, 54Tracey C Kallab, 56Jeffrey A Kallach, 60Devica P Kalladeen, 57

Rao Kalla Phones & Addresses

  • Foster City, CA
  • 10654 Gardena Ct, Cupertino, CA 95014
  • 20800 Valley Green Dr, Cupertino, CA 95014
  • 125 Connemara Way, Sunnyvale, CA 94087
  • 2420 Espina St, Las Cruces, NM 88001
  • Mountain View, CA
  • Santa Clara, CA

Work

Company: Gilead sciences Jan 2011 Position: Senior scientist

Education

Degree: MBA School / High School: Golden Gate University 2010 to 2012

Skills

Medicinal Chemistry • Drug Discovery • Drug Design • Drug Development • Biotechnology • Organic Chemistry • Organic Synthesis • Chromatography

Industries

Pharmaceuticals

Resumes

Resumes

Rao Kalla Photo 1

Senior Scientist At Gilead Sciences

View page
Position:
Senior Scientist at Gilead Sciences
Location:
San Francisco Bay Area
Industry:
Pharmaceuticals
Work:
Gilead Sciences since Jan 2011
Senior Scientist
Gilead Sciences Apr 2009 - Jan 2011
Research Scientist II
CV Therapeutics Jan 2002 - Apr 2009
Senior Scientist
New Mexico State University, Las Cruces Dec 1997 - Jan 2002
Staff Scientist, Post Doctoral Fellow
Dr. Reddys Research Foundation 1995 - 1997
Scientist
Education:
Golden Gate University 2010 - 2012
MBA University of Hyderabad 1989 - 1995
Ph.D., Organic Chemistry University of Hyderabad 1987 - 1989
M.Sc, Chemistry SKBR College 1982 - 1987
B.Sc., Mathematics, Physics, Chemistry
Skills:
Medicinal Chemistry
Drug Discovery
Drug Design
Drug Development
Biotechnology
Organic Chemistry
Organic Synthesis
Chromatography

Publications

Us Patents

A2B Adenosine Receptor Antagonists

View page
US Patent:
6825349, Nov 30, 2004
Filed:
Nov 8, 2002
Appl. No.:
10/290921
Inventors:
Rao Kalla - Mountain View CA
Thao Perry - San Jose CA
Elfatih Elzein - Fremont CA
Vaibhav Varkhedkar - San Diego CA
Xiaofen Li - Palo Alto CA
Prabha Ibrahim - Mountain View CA
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO
Jeff Zablocki - Mountain View CA
Assignee:
CV Therapeutics Inc. - Palo Alto CA
International Classification:
C07D47312
US Classification:
544267, 544269, 544270, 544271, 544272
Abstract:
Disclosed are novel A adenosine receptor antagonists compounds having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

A2B Adenosine Receptor Antagonists

View page
US Patent:
6977300, Dec 20, 2005
Filed:
May 6, 2003
Appl. No.:
10/431167
Inventors:
Rao Kalla - Mountain View CA, US
Thao Perry - San Jose CA, US
Elfaith Elzein - Fremont CA, US
Vaibhav Varkhedkar - San Diego CA, US
Xiaofen Li - Palo Alto CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D473/04
A61K031/522
A61P035/00
A61P011/06
A61P025/16
US Classification:
544269, 544267, 544270, 544271, 544272
Abstract:
Disclosed are novel Aadenosine receptor antagonists having the structure of Formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

A1 Adenosine Receptor Antagonists

View page
US Patent:
7022710, Apr 4, 2006
Filed:
Jul 22, 2004
Appl. No.:
10/897047
Inventors:
Jeff Zablocki - Mountain View CA, US
Rao Kalla - Cupertino CA, US
Dewan Zeng - San Mateo CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31/52
US Classification:
5142632
Abstract:
Disclosed are novel methods of antagonizing the Aadenosine receptor in a mammal, comprising administering to a mammal in need thereof a therapeutically effective dose of a compound of the formula: wherein Ris optionally substituted Calkyl; Y is Calkylene; and Z is phenyl that is optionally substituted with halo, hydroxy, amino, cyano, or optionally substituted Calkyl or a pharmaceutically acceptable salt, ester, or prodrug thereof. The Aadenosine receptors are antagonized in order to treat a disease state is chosen from renal failure, renal dysfunction, nephritis, hypertension, edema, Alzheimers disease, stress, depression, cardiac arrhythmia, restoration of cardiac function, congestive heart failure, diabetes, asthma, respiratory disorders, ischemia-induced injury of the brain, heart and kidney, and diarrhea.

Aadenosine Receptor Antagonists

View page
US Patent:
7105665, Sep 12, 2006
Filed:
Sep 23, 2004
Appl. No.:
10/947708
Inventors:
Rao Kalla - Cupertino CA, US
Thao Perry - San Jose CA, US
Elfatih Elzein - Fremont CA, US
Vaibhav Varkhedkar - San Diego CA, US
Xiaofen Li - Palo Alto CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D 473/04
C07D 473/06
C07D 473/08
A61K 31/522
A61P 9/10
US Classification:
544270, 544267, 544269, 544271, 544272
Abstract:
Disclosed are methods for making novel Aadenosine receptor antagonists having the structure of formula I or Formula II:.

Aadenosine Receptor Antagonists

View page
US Patent:
7125993, Oct 24, 2006
Filed:
Nov 21, 2003
Appl. No.:
10/719102
Inventors:
Elfatih Elzein - Fremont CA, US
Rao Kalla - Cupertino CA, US
Tim Marquart - Mountain View CA, US
Jeff Zablocki - Mountain View CA, US
Xiaofen Li - Palo Alto CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D 473/04
C07D 473/06
C07D 473/08
C07D 247/02
C07D 239/545
US Classification:
544270, 544267, 544269, 544271, 544272, 544310, 544312
Abstract:
Disclosed are processes for the synthesis of novel compounds that are Aadenosine receptor antagonists, having the structure of Formula I or Formula II:.

Aadenosine Receptor Antagonists

View page
US Patent:
7304070, Dec 4, 2007
Filed:
Sep 16, 2004
Appl. No.:
10/942582
Inventors:
Rao Kalla - Cupertino CA, US
Thao Perry - San Jose CA, US
Elfatih Elzein - Fremont CA, US
Vaibhav Varkhedkar - San Diego CA, US
Xiaofen Li - Palo Alto CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D 473/06
A61K 31/522
A61P 25/28
A61P 11/06
A61P 25/16
US Classification:
5142632, 544267, 544269, 544270, 544271, 544272, 544311, 544312, 5483265, 5483741, 548131
Abstract:
Disclosed are novel Aadenosine receptor antagonists having the structure of Formula I or Formula II:.

Aadenosine Receptor Antagonists

View page
US Patent:
7317017, Jan 8, 2008
Filed:
Jul 25, 2005
Appl. No.:
11/189202
Inventors:
Rao Kalla - Mountain View CA, US
Thao Perry - San Jose CA, US
Elfatih Elzein - Fremont CA, US
Vaibhav Varkhedkar - San Diego CA, US
Xiaofen Li - Palo Alto CA, US
Prabha Ibrahim - Mountain View CA, US
Venkata Palle - Gurgaon, IN
Dengming Xiao - Longmont CO, US
Jeff Zablocki - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
C07D 473/12
C07D 473/06
C07D 473/04
A61K 51/522
A61P 11/06
US Classification:
5142632, 51426322, 51426334, 544267, 544269, 544270, 544271, 544272
Abstract:
Disclosed are novel Aadenosine receptor antagonists having the structure of Formula I or Formula II.

A1 Adenosine Receptor Agonists

View page
US Patent:
7381714, Jun 3, 2008
Filed:
May 19, 2006
Appl. No.:
11/437774
Inventors:
Elfatih Elzein - Fremont CA, US
Rao Kalla - Sunnyvale CA, US
Thao Perry - San Jose CA, US
Jeff Zablocki - Mountain View CA, US
Xiaofen Li - Mountain View CA, US
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31/70
C07H 19/167
US Classification:
514 46, 536 2722, 536 2723, 536 2761
Abstract:
Disclosed are novel compounds that are partial and full Aadenosine receptor agonists having the structure of Formula I:.
Control profile
Rao V Kalla from Foster City, CA, age ~58 Get Report